# LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

> **NCT05410951** · — · ACTIVE_NOT_RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 800 (estimated)

## Conditions studied

- Lobular Breast Carcinoma
- Lobular in Situ Breast Carcinoma
- BRCA1 Mutation
- BRCA2 Mutation

## Interventions

- **DIAGNOSTIC_TEST:** Illumina panel

## Key facts

- **NCT ID:** NCT05410951
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-16
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410951, "LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05410951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*